Failure of complete recanalization is associated with poor outcome after cardioembolic stroke

European Journal of Neurology

Volumn 18, Issue 9, 2011, Pages 1171-1178

  Nam, H S ^a   Lee, K Y ^a   Kim, Y D ^a   Choi, H Y ^a   Cho, H J ^a   Cha, M J ^a   Nam, C M ^a   Heo, J H ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cardiac embolism; Cerebral infarction; Prognosis; Thrombolytic therapy

Indexed keywords

ALTEPLASE; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN INFARCTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; STROKE PATIENT;

AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; FEMALE; HEART DISEASES; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 80051592547     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03360.x     Document Type: Article

References (37)

1. Han SW, Nam HS, Kim SH, Lee JY, Lee KY, Heo JH. Frequency and significance of cardiac sources of embolism in the TOAST classification. Cerebrovasc Dis 2007; 24: 463-468.
2. Bogousslavsky J, Cachin C, Regli F, Despland P-A, Melle GV, Kappenberger L. Cardiac sources of embolism and cerebral infarction - clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology 1991; 41: 855-859.
3. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004; 35: 486-490.
4. Timsit SG, Sacco RL, Mohr JP, et al. Brain infarction severity differs according to cardiac or arterial embolic source. Neurology 1993; 43: 728-733.
5. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38: 967-973.
6. Broderick J, Phillips S, O'Fallon W, Frye R, Whisnant J. Relationship of cardiac disease to stroke occurrence, recurrence, and mortality. Stroke 1992; 23: 1250-1256.
7. Ueda T, Sakaki S, Kumon Y, Ohta S. Multivariable analysis of predictive factors related to outcome at 6months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999; 30: 2360-2365.
8. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 1996; 27: 1765-1769.
9. Lin H-J, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation: the Framingham Study. Stroke 1996; 27: 1760-1764.
10. Lee KY, Kim DI, Kim SH, et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004; 25: 1470-1475.
11. Heo JH, Lee KY, Kim SH, Kim DI. Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study. Neurology 2003; 60: 1684-1687.
12. Lee KY, Heo JH, Lee SI, Yoon PH. Rescue treatment with abciximab in acute ischemic stroke. Neurology 2001; 56: 1585-1587.
13. Nam HS, Lee KY, Han SW, et al. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients. J Neurol Sci 2009; 281: 69-73.
14. Lee KY, Han SW, Kim SH, et al. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 2007; 38: 192-193.
15. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
16. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-154.
17. Zangerle A, Kiechl S, Spiegel M, et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology 2007; 68: 39-44.
18. Kim EY, Heo JH, Lee SK, et al. Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT. Neurology 2006; 67: 1846-1848.
19. Marder VJ, Chute DJ, Starkman S, et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006; 37: 2086-2093.
20. Urbach H, Hartmann A, Pohl C, et al. Local intra-arterial thrombolysis in the carotid territory: does recanalization depend on the thromboembolus type? Neuroradiology 2002; 44: 695-699.
21. Alexandrov AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 2000; 31: 610-614.
22. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178.
23. Lou M, Selim M. Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients? Cerebrovasc Dis 2009; 27: 84-90.
24. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42: 976-982.
25. Kimura K, Iguchi Y, Shibazaki K, Aoki J, Uemura J. Early recanalization rate of major occluded brain arteries after intravenous tissue plasminogen activator therapy using serial magnetic resonance angiography studies. Eur Neurol 2009; 62: 287-292.
26. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV. Is the benefit of early recanalization sustained at 3months? A prospective cohort study Stroke 2003; 34: 695-698.
27. Ribo M, Alvarez-Sabin J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-1004.
28. Kammler J, Kypta A, Hofmann R, et al. TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol 2009; 98: 165-170.
29. Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hill MD, Alexandrov AV. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007; 38: 961-966.
30. Liebeskind DS. Collateral Circulation. Stroke 2003; 34: 2279-2284.
31. Bang OY, Saver JL, Buck BH, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008; 79: 625-629.
32. Kim YD, Lee JH, Jung YH, et al. Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use. J Neurol Sci 2010; 298: 101-105.
33. Terruso V, D'Amelio M, Di Benedetto N, et al. Frequency and determinants for hemorrhagic transformation of cerebral infarction. Neuroepidemiology 2009; 33: 261-265.
34. Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a Prospective Multicenter Study. Stroke 2008; 39: 2249-2256.
35. Saqqur M, Tsivgoulis G, Molina CA, et al. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Neurology 2008; 71: 1304-1312.
36. Cho HJ, Choi HY, Kim YD, et al. Transoesophageal echocardiography in patients with acute stroke with sinus rhythm and no cardiac disease history. J Neurol Neurosurg Psychiatry 2010; 81: 412-415.
37. Barreto AD, Albright KC, Hallevi H, et al. Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke. Stroke 2008; 39: 3231-3235.